{"nct_id":"NCT03639194","title":"A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer","status":"COMPLETED","status_verified_date":"2024-02","start_date":"2018-10-24","start_date_type":"ACTUAL","primary_completion_date":"2024-01-25","primary_completion_date_type":"ACTUAL","completion_date":"2024-01-25","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}